End-Stage Renal Disease Market Size, Value, and Competitive Overview:
[180 Pages Research Report] The global End Stage Renal Disease Market size was valued at USD 85 billion in 2023, and the market is projected to reach USD 190.3 billion by the end of 2030, with growth at a CAGR of 12.2% during the forecast report 2023-2030.
Kidneys that can no longer perform their functions properly are said to have End Stage Renal Disease (ESRD). When the kidneys don't function properly, toxins can build up in the body and cause major problems since they are essential for filtering waste and extra fluid from circulation.
ESRD normally progresses over months or years and can be brought on by a number of underlying medical disorders, including diabetes, hypertension, and glomerulonephritis. Dialysis and kidney transplantation are the two most popular ESRD treatments.
During a kidney transplant, a healthy kidney from a live or deceased donor is surgically placed in place of the failing kidney. On the other hand, a technique known as dialysis employs a machine to filter waste.
Anaemia, bone disease, cardiovascular disease, and neuropathy are just a few of the problems that can result from ESRD. People with ESRD may have considerable reductions in quality of life as a result of these consequences, which need constant medical treatment and observation.
Maintaining a healthy lifestyle, addressing underlying medical diseases like diabetes and hypertension, and finding and treating renal disease early all contribute to preventing ESRD. Urine and blood screening tests can help identify kidney illness early on and stop it from progressing to end-stage renal disease (ESRD).
Technological Developments: The ESRD market is seeing quick technological development, which is resulting in the creation of new, more effective and efficient treatment choices. For instance, novel dialysis modalities like peritoneal dialysis and the development of wearable prosthetic kidneys are altering how ESRD is handled.
Globally, the prevalence of chronic kidney disease (CKD) is rising as a result of ageing populations, an increase in diabetes and hypertension cases, and lifestyle modifications. Since CKD is a significant risk factor for ESRD, the market for ESRD products is expanding as CKD is becoming more common.
Favourable Reimbursement Policies: The market is expanding as a result of governments and commercial payers developing favourable reimbursement policies for ESRD therapies.
rising Emphasis on Early Identification and Screening: As CKD and ESRD are becoming more well-known, there is a rising emphasis on early identification and screening. The market for ESRD screening and diagnostic tests is expanding since early diagnosis can stop or slow the course of ESR. Growing senior Population: As a result of the senior population's increased risk of developing ESRD, the market for ESRD products is expanding. Due to the rising prevalence of CKD, technological advancements, and favourable reimbursement policies, the ESRD market is anticipated to expand over the coming years. The high cost of ESRD medicines and the requirement for more efficient and affordable treatments are both obstacles in the market.
As per the report, the global End Stage Renal Disease Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
by Type
• Transplant
• Peritoneal Dialysis
• Hemodialysis
• Wearable Artificial Kidney
Geographical Classification Analysis:
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
Regional Insights:
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Nipro Corporation
• B Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• Medtronic Plc
• B. Braun Holding GmbH & Co. KG
• Becton, Dickinson, and Company
• Asahi Kasei Corporation
• Cantel Medical Corproration
• Nikkiso Co., Ltd.
• JMS Co. Ltd.
*List not exhaustive
1. Executive Summary
1.1 Introduction to End Stage Renal Disease Markets
1.2 End Stage Renal Disease Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in End Stage Renal Disease Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key End Stage Renal Disease Market Trends
3.2 Key End Stage Renal Disease Market Growth Drivers
3.3 Key End Stage Renal Disease Market Growth Restraints
4 End Stage Renal Disease Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. End Stage Renal Disease Market Segmentation- Outlook by Type
5.1 Transplant Market Outlook to 2030
5.2 Peritoneal Dialysis Market Outlook to 2030
5.3 Hemodialysis Market Outlook to 2030
5.4 Wearable Artificial Kidney Market Outlook to 2030
6. North America End Stage Renal Disease Market Outlook and Opportunities to 2030
6.1 Market Snapshot, 2023
6.2 North America End Stage Renal Disease Market Growth Opportunities
6.3 North America End Stage Renal Disease Market Outlook by Application
6.4 North America End Stage Renal Disease Market Outlook by Type
6.5 North America End Stage Renal Disease Market Outlook by Country
6.6 United States End Stage Renal Disease Market Outlook
6.7 Canada End Stage Renal Disease Market Outlook
6.8 Mexico End Stage Renal Disease Market Outlook
7. Europe End Stage Renal Disease Market Outlook and Opportunities to 2030
7.1 Market Snapshot, 2023
7.2 Europe End Stage Renal Disease Market Outlook by Application
7.3 Europe End Stage Renal Disease Market Outlook by Type
7.4 Europe End Stage Renal Disease Market Outlook by Country
7.5 Germany End Stage Renal Disease Market Outlook
7.6 France End Stage Renal Disease Market Outlook
7.7 United Kingdom End Stage Renal Disease Market Outlook
7.8 Spain End Stage Renal Disease Market Outlook
7.9 Italy End Stage Renal Disease Market Outlook
7.10 Other Europe End Stage Renal Disease Market Outlook
8. Asia Pacific End Stage Renal Disease Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 Asia Pacific End Stage Renal Disease Market Outlook by Application
8.3 Asia Pacific End Stage Renal Disease Market Outlook by Type
8.4 Asia Pacific End Stage Renal Disease Market Outlook by Country
8.5 China End Stage Renal Disease Market Outlook
8.6 Japan End Stage Renal Disease Market Outlook
8.7 India End Stage Renal Disease Market Outlook
8.8 Other Asia Pacific End Stage Renal Disease Market Outlook
9. Latin America End Stage Renal Disease Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Latin America End Stage Renal Disease Market Outlook by Application
9.3 Latin America End Stage Renal Disease Market Outlook by Type
9.4 Latin America End Stage Renal Disease Market Outlook by Country
9.5 Brazil End Stage Renal Disease Market Outlook
9.6 Argentina End Stage Renal Disease Market Outlook
9.7 Other Latin America End Stage Renal Disease Market Outlook
10. Middle East and Africa End Stage Renal Disease Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Middle East and AfricaEnd Stage Renal Disease Market Outlook by Application
10.3 Middle East and AfricaEnd Stage Renal Disease Market Outlook by Type
10.4 Middle East and AfricaEnd Stage Renal Disease Market Outlook by Country
10.5 Saudi Arabia End Stage Renal Disease Market Outlook
10.6 UAE End Stage Renal Disease Market Outlook
10.7 South Africa End Stage Renal Disease Market Outlook
10.8 Other Middle East and Africa End Stage Renal Disease Market Outlook
11 Profiles of major End Stage Renal Disease Companies
Nipro Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
B Fresenius Medical Care AG & Co. KGaA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Baxter International Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Medtronic Plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
B. Braun Holding GmbH & Co. KG
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Becton, Dickinson, and Company
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Asahi Kasei Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Cantel Medical Corproration
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Nikkiso Co., Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
JMS Co. Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
12. Appendix
12.1 Publisher’s Expertise
12.2 List of Tables and Charts
12.3 List of Exhibits
12.4 Legal Disclaimer
by Type
• Transplant
• Peritoneal Dialysis
• Hemodialysis
• Wearable Artificial Kidney